[
    [
        {
            "time": "2021-06-30",
            "original_text": "['Johnson', '&', 'Johnson', '(JNJ)', 'Stock', 'Moves', '-0.12%:', 'What', 'You', 'Should', 'Know']",
            "features": {
                "keywords": [
                    "Johnson & Johnson",
                    "stock moves",
                    "-0.12%"
                ],
                "sentiment_score": -0.1,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Johnson & Johnson (JNJ) Stock Moves -0.12%: What You Should Know",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 4,
                "Duration": 3,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-06-15",
            "original_text": "['Here's', 'Why', 'Moderna', 'Stock', 'Soared', '125%', 'During', 'the', 'First', '6', 'Months', 'of', '2021']",
            "features": {
                "keywords": [
                    "Moderna",
                    "stock soared",
                    "125%"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Here's Why Moderna Stock Soared 125% During the First 6 Months of 2021",
                "Correlation": 2,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 9,
                "Duration": 7,
                "Entity_Density": 7,
                "Market_Scope": 4,
                "Time_Proximity": 5,
                "Headline_Structure": 9,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-07-01",
            "original_text": "['AstraZeneca,', 'JNJ', 'To', 'Start', 'Research', 'On', 'Potentially', 'Modified', 'COVID-19', 'Shots:', 'WSJ']",
            "features": {
                "keywords": [
                    "AstraZeneca",
                    "JNJ",
                    "modified COVID-19 shots"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "AstraZeneca, JNJ To Start Research On Potentially Modified COVID-19 Shots: WSJ",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 8,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-06-28",
            "original_text": "['After', 'FDA', 'Warning,', 'EMA', 'Reviewing', 'J&J', 'COVID-19', 'Jab', 'For', 'Rare', 'Nerve', 'Disorder:', 'Reuters']",
            "features": {
                "keywords": [
                    "FDA Warning",
                    "EMA Reviewing",
                    "J&J",
                    "rare nerve disorder"
                ],
                "sentiment_score": -0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "After FDA Warning, EMA Reviewing J&J COVID-19 Jab For Rare Nerve Disorder: Reuters",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-07-02",
            "original_text": "['Can', 'J&J', 'Break', 'Out', 'to', 'Highs', 'Amid', 'COVID', 'Vaccine', 'Headlines?']",
            "features": {
                "keywords": [
                    "J&J",
                    "break out",
                    "COVID vaccine headlines"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Can J&J Break Out to Highs Amid COVID Vaccine Headlines?",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 7,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-06-29",
            "original_text": "['J&J', '(JNJ)', 'COVID-19', 'Jab', 'Linked', 'to', 'New', 'Rare', 'Neurological', 'Disorder']",
            "features": {
                "keywords": [
                    "J&J",
                    "COVID-19 Jab",
                    "rare neurological disorder"
                ],
                "sentiment_score": -0.8,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "J&J (JNJ) COVID-19 Jab Linked to New Rare Neurological Disorder",
                "Correlation": 10,
                "Sentiment": 2,
                "Importance": 10,
                "Impact": 9,
                "Duration": 9,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-06-25",
            "original_text": "['UPDATE', '1-EU', 'reviews', 'J&J', 'COVID-19', 'shot', 'for', 'rare', 'nerve', 'disorder', 'after', 'U.S.', 'warning']",
            "features": {
                "keywords": [
                    "EU reviews",
                    "J&J",
                    "rare nerve disorder",
                    "U.S. warning"
                ],
                "sentiment_score": -0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "UPDATE 1-EU reviews J&J COVID-19 shot for rare nerve disorder after U.S. warning",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 7,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-06-24",
            "original_text": "['UPDATE', '1-J&J,', 'AstraZeneca', 'explore', 'COVID-19', 'vaccine', 'modification', 'after', 'blood', 'clot', 'reports', '-', 'WSJ']",
            "features": {
                "keywords": [
                    "J&J",
                    "AstraZeneca",
                    "vaccine modification",
                    "blood clot reports"
                ],
                "sentiment_score": 0.4,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "UPDATE 1-J&J, AstraZeneca explore COVID-19 vaccine modification after blood clot reports - WSJ",
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 8,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-06-23",
            "original_text": "['EMA', 'analyses', 'J&J', 'COVID-19', 'vaccine', 'data', 'for', 'cases', 'of', 'rare', 'nerve', 'disorder']",
            "features": {
                "keywords": [
                    "EMA analyses",
                    "J&J",
                    "rare nerve disorder"
                ],
                "sentiment_score": -0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "EMA analyses J&J COVID-19 vaccine data for cases of rare nerve disorder",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-06-22",
            "original_text": "['FDA', 'Warns', 'J&J’s', 'COVID-19', 'Vaccine', 'Can', 'Cause', 'Complications', '—', 'Report']",
            "features": {
                "keywords": [
                    "FDA Warns",
                    "J&J",
                    "complications"
                ],
                "sentiment_score": -0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "FDA Warns J&J’s COVID-19 Vaccine Can Cause Complications — Report",
                "Correlation": 10,
                "Sentiment": 2,
                "Importance": 10,
                "Impact": 9,
                "Duration": 9,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        }
    ]
]